Hilton Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Hilton Capital Management's CRL Position: Q2 2025 in Review
Hilton Capital Management sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 9,052 shares — an estimated $1.36M sold.
Hilton Capital Management first reported a position in CRL in Q1 2019 and held it in 15 quarters. The position peaked at $1.72M in Q1 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.
- Hilton Capital Management reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
- Hilton Capital Management sold 9,052 Charles River Laboratories shares in Q2 2025, an estimated $1.36M.
- Hilton Capital Management first reported a position in Charles River Laboratories in Q1 2019 and held it in 15 quarters.
- Hilton Capital Management's Charles River Laboratories position peaked at $1.72M in Q1 2024.
- 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.
Based on Hilton Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.